Document Detail


An infant with self-healing cutaneous Langerhans cell histiocytosis followed by isolated thymic relapse.
MedLine Citation:
PMID:  19343774     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thymic involvement with Langerhans cell histiocytosis (LCH) typically occurs in children as part of multi-system (M-S) LCH. Patients who develop skin-only LCH during infancy may either follow a self-healing course with spontaneous regression or may progress to M-S involvement. We describe a male infant who developed isolated thymic LCH after spontaneous complete regression of isolated cutaneous lesions. His erythrocyte sedimentation rate and C-reactive protein increased temporarily during the skin-only stage of LCH, and increased again considerably during the thymic relapse. Even for patients with skin-only LCH, these laboratory data might indicate possible relapse or late progression of the disease.
Authors:
Naoki Hatakeyama; Tsukasa Hori; Masaki Yamamoto; Ineko Sogawa; Natsuko Inazawa; Hiroyuki Tsutsumi; Nobuhiro Suzuki
Related Documents :
16650214 - Impairment of skin barrier function is not inherent in atopic dermatitis patients: a pr...
19646134 - Bathing and cleansing in newborns from day 1 to first year of life: recommendations fro...
3399294 - Systemic candidiasis: cutaneous manifestations in low birth weight infants.
17139264 - Epigallocatechin gallate's protective effect against mmp7 in recessive dystrophic epide...
21454994 - Risk factors and outcomes for retinopathy of prematurity in neonatal infants with a bir...
17977044 - Risk of sudden death and acute life-threatening events in patients with glutaric acidem...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric blood & cancer     Volume:  53     ISSN:  1545-5017     ISO Abbreviation:  Pediatr Blood Cancer     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-06-15     Completed Date:  2009-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101186624     Medline TA:  Pediatr Blood Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  229-31     Citation Subset:  IM    
Copyright Information:
(c) 2009 Wiley-Liss, Inc.
Affiliation:
Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan. nhatake@sapmed.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Sedimentation
C-Reactive Protein / analysis
Histiocytosis, Langerhans-Cell / drug therapy,  pathology*,  physiopathology
Humans
Immunosuppressive Agents / therapeutic use
Infant
Male
Remission, Spontaneous
Skin Diseases / pathology*,  physiopathology
Thymus Gland / pathology*
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis.
Next Document:  Morphometric characterization of murine articular cartilage--novel application of confocal laser sca...